Mid-Atlantic

cures-within-reach-rare-diseasesWhile Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific geographic regions.  Therefore, in addition to our disease-specific repurposing communities, we work to increase the repurposing research focused on improving the quality and length of life within the Mid-Atlantic region through the speed and cost-effectiveness of medical repurposing.

Our events and research within the the Mid-Atlantic Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.

 

Funding Opportunity RFPs for the Mid-Atlantic:

  • US Based Repurposing Clinical Trials to Address Health Equity 2024: INVITE ONLY accepting budgets of up to $75,000 for repurposing clinical trials to address health equity, including repurposing clinical trials that EITHER are 1) led by an underrepresented researcher OR 2) address health disparities among underrepresented patients OR 3) both 1) and 2). PROPOSAL DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
  • Read about our open RFP for Impacting Blood Cancers through Clinical Repurposing Trials: clinical trials in the Mid-Atlantic are eligible! Accepting budgets of up to $75,000 from institutions worldwide for clinical repurposing trials targeting any blood cancer, with a preference for trials impacting multiple myeloma and/or myelodysplastic syndromes. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW
  • Read about our open RFP for Clinical Repurposing Research to Impact Veterans/Militaryclinical trials in the Mid-Atlantic are eligible! Accepting budgets of up to $75,000 to a U.S.-based institution for a repurposing clinical trial in any disease area impacting veterans or active military, such as mental health, PTSD and brain injuries. LOI DEADLINE CLOSED; SUBMISSIONS UNDER REVIEW

More information on our Funding Opportunities / RFPs page.

Events

Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
November 2021
Virtual
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.

Real World Data Through a Patient’s Lens
October 2021
Virtual
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.

Repurposing for Pediatric Patients: Best Practices and Lessons Learned
November 2020
Virtual
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.

How Patients Impact the 505(b)(2) Regulatory Process
October 2020
Virtual
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.

CureAccelerator Live! for Rare Diseases 2020
June 2020
Virtual
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients.

CureAccelerator Live! for Rare Diseases 2019
June 2019
Philadelphia, PA
Three finalists from the US and Italy competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients.

CureAccelerator Live! for the Developing World 2019
May 2019
Boston, MA
Five finalists from the US and India competing for up to $50,000 to fund their repurposing clinical trials impacting patients in the Developing World.

CureAccelerator Live! for the Mid-Atlantic 2018
October 2018
Washington, DC
Four finalists from Mid-Atlantic institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials.